Don’t miss the latest developments in business and finance.

Cadila Healthcare divests its entire stake in Bremer Pharma, Germany

Image
Capital Market
Last Updated : Apr 18 2018 | 9:31 AM IST

Bremer Pharma ceases to be subsidiary of Cadila Healthcare

Cadila Healthcare has divested its entire shareholding in Bremer Pharma GmbH, Germany (Bremer), a wholly owned subsidiary of the company and consequently, Bremer ceased to be a subsidiary of the company.

The company received consideration at enterprise value of Euro 22,63,431 of which share sale value is Euro 8,27,344 and loan value (extended by Zydus International - a wholly owned subsidiary of the company) is Euro 14,36,087.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Apr 18 2018 | 9:18 AM IST

Next Story